Lang & Schwarz
23.11.24
10:43 Uhr
0,028 Euro
-0,028
-100,00 %
-100,00 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,022 | 0,034 | 10:44 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.10. | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q2 2024 Financial Results and Operational Update | 5 | TheNewswire | ||
| 09.07. | Stagezero Life Sciences Ltd (2): Stagezero working on filing 2023 results by July 8 | 1 | Stockwatch | ||
| 09.07. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order | 553 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
| 04.07. | Stagezero Life Sciences Ltd (2): Stagezero has no material changes | 1 | Stockwatch | ||
| 04.07. | Stagezero Life Sciences Ltd (2): Stagezero Life has no material changes | 1 | Stockwatch | ||
| 04.07. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order | 379 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 23.05. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Failure to File Cease Trade Order | 519 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
| 17.05. | StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update | 1.281 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for... ► Artikel lesen | |
| 10.04. | XFRA 61N1: AUSSETZUNG/SUSPENSION | 217 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSTAGEZERO LIFE SCIENC.... ► Artikel lesen | |
| 05.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order | 477 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
| 03.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results | 418 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 55,45 | +1,46 % | Carl Zeiss Meditec Aktie: Am Abgrund? | Die Aktie von Carl Zeiss Meditec erlebte am Freitag einen weiteren Rückschlag an der Börse. Im XETRA-Handel verzeichnete das Papier des Medizintechnikunternehmens deutliche Einbußen und fiel zeitweise... ► Artikel lesen | |
| INTUITIVE SURGICAL | 525,50 | -0,15 % | Intuitive Surgical-Aktie erreicht 52-Wochen-Hoch bei 552 US-Dollar | ||
| PLUS THERAPEUTICS | 1,114 | +0,18 % | PSTV stock touches 52-week low at $1.14 amid market challenges | ||
| BOSTON SCIENTIFIC | 86,00 | -0,58 % | BOSTON SCIENTIFIC CORP - 8-K, Current Report | ||
| MOUNTAIN VALLEY MD | 0,019 | -2,08 % | Mountain Valley MD Holdings Inc: Mountain Valley MD talks Quicksome manufacturing work | ||
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| EMPOWER CLINICS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.07.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 30.07.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.07.2024ISIN NameCA29246V2030 EMPOWER... ► Artikel lesen | |
| LIFEWARD | 1,900 | +2,15 % | Lifeward Ltd.: Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons | ||
| SENSEONICS | 0,299 | -1,51 % | Senseonics Holdings, Inc. - 8-K, Current Report | ||
| EKSO BIONICS | 0,690 | +2,07 % | Ekso Bionics stock plunges to 52-week low of $0.71 | ||
| IMUNON | 0,795 | +1,92 % | Imunon, Inc.: IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting | IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was... ► Artikel lesen | |
| ROCKWELL MEDICAL | 2,102 | -2,50 % | Rockwell Medical-Direktor Mark H. Ravich verkauft Aktien im Wert von 70.379 US-Dollar | ||
| AVINGER | 0,789 | 0,00 % | Avinger Inc - 8-K, Current Report | ||
| MEMPHASYS | 0,004 | +14,29 % | MEMPHASYS LIMITED: Results of Meeting |
STAGEZERO LIFE SCIENCES LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -100,00 % bei einem Aktienkurs von 0,028 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STAGEZERO LIFE SCIENCES LTD finden Sie auf Wallstreet Online.
